18.7.2006: Meldung: Millipore Corp.: Acquisition of Serologicals Completed

Millipore Completes Acquisition of Serologicals
Monday July 17, 8:33 am ET
Acquisition Will Transform Millipore into a $1.4 Billion Life Science Leader with Leading Positions in Rapidly Growing Markets

BILLERICA, Mass.--July 17, 2006--Millipore Corporation announced today that it has completed its acquisition of Serologicals following approval by Serologicals" shareholders last week. The acquisition will transform Millipore into a life science industry leader with combined annual revenues of approximately $1.4 billion, based on 2006 full year projections.

"The strategic combination of Millipore and Serologicals will enable us to leverage the complementary capabilities and resources of both companies," said Martin Madaus, Chairman & CEO of Millipore. "We are gaining high-value, differentiated products in important growth segments such as drug discovery products and services, nucleic function, stem cell research, and cell culture supplements. Our combined global field organization of approximately 1,200 professionals, which includes some of the most technically advanced experts in the industry, will have the ability to sell a broad portfolio of innovative products and further expand our presence in emerging international markets. We now have a well-balanced growth profile between our Bioscience and Bioprocess Divisions, which will allow us to effectively execute our long-term strategy."

Strategic Rationale for Serologicals Acquisition

* Expands Bioscience product portfolio into fast growing markets
* Extends Bioprocess footprint into upstream biopharmaceutical manufacturing
* Accelerates revenue growth
* Increases profitability with addition of high-margin consumable products
* Establishes important critical mass

The combined organization of approximately 5,800 employees will also have significantly expanded R&D capabilities with more than 500 R&D professionals worldwide. With the addition of Serologicals" R&D capabilities, Millipore will be able to pursue new markets, accelerate investment in new products, and bring together the applications expertise of both companies to generate value for customers.

About Millipore

Millipore is a leading provider of products and services that improve productivity in biopharmaceutical manufacturing and in clinical, analytical and research laboratories. The Company is organized in two operating divisions. Its Bioprocess Division helps enables pharmaceutical and biotechnology companies to optimize their manufacturing productivity, ensure the quality of drugs, and scale up the production of difficult-to-manufacture biologics. Its Bioscience division helps to optimize laboratory productivity and workflows by providing reagents, kits and other enabling technologies and products for life science research and development. Millipore has a deep understanding of its customers" research and manufacturing process needs, and offers reliable and innovative tools, technologies and services. The Company is part of the S&P 500 index and employs approximately 5,800 employees in more than 47 offices worldwide. For additional information on Millipore Corporation, please visit its website at: www.millipore.com.


Millipore Corporation
Joshua Young, 978-715-1527 or 800-225-3384
Director, Investor Relations

Source: Millipore Corporation
Aktuell, seriös und kostenlos: Der ECOreporter-Newsletter. Seit 1999.
Nach oben scrollen
ECOreporter Journalistenpreise